NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 998 coverMYASTHENIA GRAVIS AND RELATED DISORDERS: Biochemical Basis for Disease of the Neuromuscular Junction Volume 998 published September 2003
Ann. N.Y. Acad. Sci. 998: 41 (2003). doi: 10.1196/annals.1254.007
Copyright © 2003 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by LINDSTROM, J. M.
Search for Related Content
PubMed
PubMed Citation
Articles by LINDSTROM, J. M.
Nicotinic Acetylcholine Receptors of Muscles and Nerves

Comparison of Their Structures, Functional Roles, and Vulnerability to Pathology

JON M. LINDSTROM

Medical School of the University of Pennsylvania, Philadelphia, Pennsylvania, USA

Address for correspondence: Jon M. Lindstrom, Medical School of the University of Pennsylvania, 217 Stemmler Hall, Philadelphia, PA 19104-6074. Voice: 215-573-2859; fax: 215-573-2858.
JSLKK{at}mail.med.upenn.edu
Ann. N.Y. Acad. Sci. 998: 41-52 (2003).

There are fetal and adult subtypes of muscle nicotinic receptors (AChRs), whose structures and functional roles are reasonably well known. Mutations of their subunits cause congenital myasthenic syndromes. An autoimmune response to them causes myasthenia gravis (MG). The main immunogenic region (MIR) on muscle AChRs accounts for many aspects of the pathological mechanisms by which the autoimmune response impairs neuromuscular transmission. There are many other AChR subtypes, each defined by a different combination of subunits, some of which are transiently expressed in muscle during development, others of which are expressed in keratinocytes, vascular and bronchial epithelia, and other nonneuronal cells, as well as in a wide variety of neurons. Their varied structures and functional roles are much less well known. Mutations in subunits of some of these AChRs have thus far been associated with rare forms of epilepsy and dysautonomia, but other genetic diseases associated with them probably remain to be discovered. Autoimmune responses to some of these subunits are associated with rare dysautonomias and a skin disease. The pathological mechanisms by which these autoimmune responses impair function are much less well known than in the case of MG. AChRs may provide useful drug targets in several neurological diseases. By far, the biggest direct medical impact of AChRs is addiction to tobacco, which is mediated by nicotine acting on a variety of neuronal AChRs.

Key Words: AChR • nicotine • neuron • muscle • myasthenia gravis (MG)




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Razani-Boroujerdi, R. T. Boyd, M. I. Davila-Garcia, J. S. Nandi, N. C. Mishra, S. P. Singh, J. C. Pena-Philippides, R. Langley, and M. L. Sopori
T Cells Express {alpha}7-Nicotinic Acetylcholine Receptor Subunits That Require a Functional TCR and Leukocyte-Specific Protein Tyrosine Kinase for Nicotine-Induced Ca2+ Response
J. Immunol., September 1, 2007; 179(5): 2889 - 2898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Lyukmanova, Z. O. Shenkarev, A. A. Schulga, Y. S. Ermolyuk, D. Yu. Mordvintsev, Y. N. Utkin, M. A. Shoulepko, R. C. Hogg, D. Bertrand, D. A. Dolgikh, et al.
Bacterial Expression, NMR, and Electrophysiology Analysis of Chimeric Short/Long-chain {alpha}-Neurotoxins Acting on Neuronal Nicotinic Receptors
J. Biol. Chem., August 24, 2007; 282(34): 24784 - 24791.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. P. Hirsch
Neuromuscular junction in health and disease
Br. J. Anaesth., July 1, 2007; 99(1): 132 - 138.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Salminen, J. A. Drapeau, J. M. McIntosh, A. C. Collins, M. J. Marks, and S. R. Grady
Pharmacology of {alpha}-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice
Mol. Pharmacol., June 1, 2007; 71(6): 1563 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. C.-l. Lam, L. Girard, R. Ramirez, W.-s. Chau, W.-s. Suen, S. Sheridan, V. P.C. Tin, L.-p. Chung, M. P. Wong, J. W. Shay, et al.
Expression of Nicotinic Acetylcholine Receptor Subunit Genes in Non-Small-Cell Lung Cancer Reveals Differences between Smokers and Nonsmokers
Cancer Res., May 15, 2007; 67(10): 4638 - 4647.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Alkondon, E. F. R. Pereira, M. C. Potter, F. C. Kauffman, R. Schwarcz, and E. X. Albuquerque
Strain-Specific Nicotinic Modulation of Glutamatergic Transmission in the CA1 Field of the Rat Hippocampus: August Copenhagen Irish Versus Sprague-Dawley
J Neurophysiol, February 1, 2007; 97(2): 1163 - 1170.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. F. Saccone, A. L. Hinrichs, N. L. Saccone, G. A. Chase, K. Konvicka, P. A.F. Madden, N. Breslau, E. O. Johnson, D. Hatsukami, O. Pomerleau, et al.
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs
Hum. Mol. Genet., January 1, 2007; 16(1): 36 - 49.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Shimomura, M. Yokota, M. Ihara, M. Akamatsu, D. B. Sattelle, and K. Matsuda
Role in the Selectivity of Neonicotinoids of Insect-Specific Basic Residues in Loop D of the Nicotinic Acetylcholine Receptor Agonist Binding Site
Mol. Pharmacol., October 1, 2006; 70(4): 1255 - 1263.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Person, K. L. Bills, H. Liu, S. K. Botting, J. Lindstrom, and G. B. Wells
Extracellular Domain Nicotinic Acetylcholine Receptors Formed by {alpha}4 and {beta}2 Subunits
J. Biol. Chem., December 2, 2005; 280(48): 39990 - 40002.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. H. N. Celie, R. V. Klaassen, S. E. van Rossum-Fikkert, R. van Elk, P. van Nierop, A. B. Smit, and T. K. Sixma
Crystal Structure of Acetylcholine-binding Protein from Bulinus truncatus Reveals the Conserved Structural Scaffold and Sites of Variation in Nicotinic Acetylcholine Receptors
J. Biol. Chem., July 15, 2005; 280(28): 26457 - 26466.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Law, R. H. Henchman, and J. A. McCammon
Chemical Theory and Computation Special Feature: A gating mechanism proposed from a simulation of a human {alpha}7 nicotinic acetylcholine receptor
PNAS, May 10, 2005; 102(19): 6813 - 6818.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Akk, L. S Milescu, and M. Heckmann
Activation of heteroliganded mouse muscle nicotinic receptors
J. Physiol., April 15, 2005; 564(2): 359 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Sala, J. Mulet, S. Sala, S. Gerber, and M. Criado
Charged Amino Acids of the N-terminal Domain Are Involved in Coupling Binding and Gating in {alpha}7 Nicotinic Receptors
J. Biol. Chem., February 25, 2005; 280(8): 6642 - 6647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Culetto, H. A. Baylis, J. E. Richmond, A. K. Jones, J. T. Fleming, M. D. Squire, J. A. Lewis, and D. B. Sattelle
The Caenorhabditis elegans unc-63 Gene Encodes a Levamisole-sensitive Nicotinic Acetylcholine Receptor {alpha} Subunit
J. Biol. Chem., October 8, 2004; 279(41): 42476 - 42483.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Tsuneki, Y. You, N. Toyooka, S. Kagawa, S. Kobayashi, T. Sasaoka, H. Nemoto, I. Kimura, and J. A. Dani
Alkaloids Indolizidine 235B', Quinolizidine 1-epi-207I, and the Tricyclic 205B are Potent and Selective Noncompetitive Inhibitors of Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2004; 66(4): 1061 - 1069.
[Abstract] [Full Text] [PDF]



footerLeft footerRight